Publications

The ACPCC’s research team (in collaboration with our key partners) continues to undertake research and evaluation of public health activities supporting cervical cancer elimination in Australia and internationally, with outcomes published in peer-reviewed journals and health-care focussed articles.

Search publications:

Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens.

Authors: Haqshenas G Molano M Phillips S Balgovind P

Arch Pathol Lab Med. 2024 Mar 1;148(3):353-358. doi: 10.5858/arpa.2022-0317-OA.

Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study.

Authors: Yuill S Egger S Smith MA Velentzis L

J Med Screen. 2024 Mar;31(1):35-45. doi: 10.1177/09691413231184334

From commitments to action: the first global cervical cancer elimination forum.

Authors: Almonte M Ilbawi AM Maza M Saville M

Lancet Reg Health Am. 2024 Jun 12;36:100812. doi: 10.1016/j.lana.2024.100812.

Criteria for second generation comparator tests invalidation of novel HPV DNA tests for use in cervical cancer screening.

Authors: Arbyn M. Cuschieri K Bonde J, Schuurman R

J Med Virol. 2024 Sep;96(9):e29881. doi: 10.1002/jmv.29881

Practitioners support and intention to adopt universal access to self-collection in Australia’s National Cervical Screening Program.

Authors: Creagh NS Saunders T Brotherton J Hocking J

Cancer Med. 2024 May;13(10):e7254. doi: 10.1002/cam4.7254.

Performance of CADM1, MAL and miR124-2 methylation as triage markers for early detection of cervical cancer in self-collected and clinician-collected samples: an exploratory observational study in Papua New Guinea.

Authors: Molano M Machalek DA Tan G Garland S

BMJ Open. 2024 Jun 19;14(6):e081282. doi: 10.1136/bmjopen-2023-081282.

DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging.

Authors: Molano M Machalek DA Phillips S Tan G

Tumour Virus Res. 2024 Jul 1;18:200288. doi: 10.1016/j.tvr.2024.200288

Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.

Authors: Mehta, N Keung, M. H. T Pineda, E. Lynn, E

Microbiology spectrum

I’m due for a cervical cancer screening. What can I expect? Can I do it myself? And what happened to Pap smears?

Authors: Canfell, K Bateson, D Smith, M Saville, M

The Conversation

Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study

Authors: Louiza S. Velentzis Sam Egger Jo Waller Chloe J Jennett

Preventative Medicine Reports

From commitments to action: the first global cervical cancer elimination forum

Authors: Maribel Almonte Andre Michael Ilbawi Mauricio Maza Marion Saville

The Lancet

Practitioners support and intention to adopt universal access to self-collection in Australia’s National Cervical Screening Program

Authors: Creagh NS Saunders T Brotherton J Hocking J

Cancer Med 2024; 13:e7254.

Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens.

Authors: Haqshenas, G. Molano, M. Phillips, S Balgovind, P

Archives of pathology & laboratory medicine, 148(3), 353–358.

Assessing Canadian women’s preferences for cervical cancer screening: A brief report.

Authors: Zhu P Tatar O Haward B Griffin-Mathieu G

Public Health 2022;10:962039. doi: 10.3389/fpubh.2022.962039

So, if she wasn’t aware of it, then how would everybody else out there be aware of it?”—Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia’s Cervical Screening Program: A Qualitative Study. 

Authors: Zammit, C.M Creagh, N.S McDermott, T Smith, M.A

Int. J. Environ. Res. Public Health 2022, 19, 15776.

Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.

Authors: Thompson EF Hoang L Höhn AK Palicelli A

Int J Gynecol Cancer. 2022 Aug 1;32(8):977-985. doi: 10.1136/ijgc-2021-003251. PMID: 35764349.

Supporting gynaecological pathology: volunteering at home and abroad.

Authors: Talia KL van der Griend R

Pathology. Volume 55. Supplement 1, S3, February 2023

Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.

Authors: Talia KL Ratnayake G McCluggage WG

International Journal of Gynecological Pathology 42(5):p 496-499, September 2023. | DOI: 10.1097/PGP.0000000000000915

Publications & Reports

News & Media Coverage

Events

Our Partners

READ UP ON IT

Eliminating Cervical Cancer 2024 Conference WRAP

The Eliminating Cervical Cancer 2024 Conference in Melbourne, held from November 27–29, has successfully concluded. We extend our deepest thanks to all who participated and contributed to the event’s success. Your active engagement, insightful…

Historic MOU Signed Between ACPCC and Gavi, Advancing Global Efforts to Eliminate Cervical Cancer

Canberra, Australia – In a landmark event, the Australian Centre for the Prevention of Cervical Cancer (ACPCC) has signed a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to strengthen collaborative efforts in…

Quad Countries Launch Cancer Moonshot Initiative to Reduce the Burden of Cancer in the Indo-Pacific

Getting everyone on board to eliminate cervical cancer by 2035

I’m due for a cervical cancer screening. What can I expect? Can I do it myself? And what happened to Pap smears?

Time to register for ECC2024

ECC2024 Melbourne The Eliminating Cervical Cancer 2024 (ECC2024) Conference, scheduled for 27th to 29th November in Melbourne, marks a pivotal moment in the global fight against cervical cancer. At this conference, the expansion of Australian expertise…

Publication of Compass-PLUS study findings

ACPCC’s National Self-Collection Campaign

In September 2024, a nationwide, government-funded cervical screening campaign promoting self-collection is commencing and is expected to result in a substantial increase in patient demand. The ACPCC is supporting healthcare providers to prepare for…

Congratulations to Professor Karen Canfell, Companion of the Order of Australia

ECC2024 Conference: Early Bird rates extended to 14 June

The Eliminating Cervical Cancer 2024 (ECC2024) Conference, 27-29 November in Melbourne, marks a pivotal moment in the global fight against cervical cancer. ECC2024 will launch the expansion of Australian expertise into eight countries in…

Australia amongst the first countries globally to reach cervical screening targets: new report finds that Australia has met the WHO and Australian 2030 cervical cancer elimination scale-up target for screening

MEDIA RELEASE Australia has reached the 2030 WHO elimination scale-up target for cervical screening coverage, well ahead of schedule, and is on track to become one of the first countries in the world to…

Growing number of patients DIY-ing cervical screening to detect HPV

Make an Individual Donation

Et has minim elitr intellegat. Mea aeterno eleifend.Et has minim elitr intellegat. Mea aeterno eleifend.Et has minim elitr inte
llegat. Mea aeterno eleifend.Et has minim elitr intellegat. Mea aeterno eleifend.Et has minim elitr intellegat. Mea aeterno eleifend.

READ UP ON IT

Get in touch

To find out more about what we do or how we can work together, please get in touch.

Publications

Search publications:

Arch Pathol Lab Med. 2024 Mar 1;148(3):353-358. doi: 10.5858/arpa.2022-0317-OA.

J Med Screen. 2024 Mar;31(1):35-45. doi: 10.1177/09691413231184334

Lancet Reg Health Am. 2024 Jun 12;36:100812. doi: 10.1016/j.lana.2024.100812.

J Med Virol. 2024 Sep;96(9):e29881. doi: 10.1002/jmv.29881

Cancer Med. 2024 May;13(10):e7254. doi: 10.1002/cam4.7254.

BMJ Open. 2024 Jun 19;14(6):e081282. doi: 10.1136/bmjopen-2023-081282.

Tumour Virus Res. 2024 Jul 1;18:200288. doi: 10.1016/j.tvr.2024.200288

Microbiology spectrum

The Conversation

Preventative Medicine Reports

The Lancet

Cancer Med 2024; 13:e7254.

Archives of pathology & laboratory medicine, 148(3), 353–358.

Public Health 2022;10:962039. doi: 10.3389/fpubh.2022.962039

Int. J. Environ. Res. Public Health 2022, 19, 15776.

Int J Gynecol Cancer. 2022 Aug 1;32(8):977-985. doi: 10.1136/ijgc-2021-003251. PMID: 35764349.

Pathology. Volume 55. Supplement 1, S3, February 2023

International Journal of Gynecological Pathology 42(5):p 496-499, September 2023. | DOI: 10.1097/PGP.0000000000000915

Publications & Reports

News & Media Coverage

Events

Our Partners

READ UP ON IT

Related News Article

DONATIONS

Make an Individual Donation

READ UP ON IT

Success Stories

Get in touch

PAGES

CONTACT DETAILS

Search our site

Download "How to take your own HPV test"

Available in your language.

Int. J. Environ. Res. Public Health 2022, 19, 15776.